Who we are
We are a team of experienced clinical research professionals, and are ready to work with you to realise your research goals in Australia/ Asia Pacific region and the USA.
Our directors Anne De Luca, Robin Hansen and George Zafiris are able to leverage over 70 years’ collective experience in all facets of clinical trials to ensure Molecule2Market consistently delivers successful client outcomes.
Meet OUR Management team
ROBIN HANSEN
Co-founder and Director of M2M
ANNE DE LUCA
Co-founder and Director of M2M
GEORGE ZAFIRIS
Director of M2M
ARI DEARNLEY
Clinical Operations Manager
MARY CARDONE
Medical Writing Manager
INGRID LOS
Clinical Operations Manager/Auditor and QA Manager
LEONIE HARRISON
Senior Clinical Research Consultant
KAREN DALEY
Senior Clinical Research Consultant
JENNIFER WINDRED
Senior Clinical Research Consultant
Our commitment
To work in collaboration with the pharmaceutical and biotechnology industries to improve health outcomes through the efficient and ethical advancement of innovative medical treatments.
Our Experience
Molecule2Market consultants are hand picked for their clinical research experience, therapeutic area expertise, and commitment to the client. Each of our projects is led by a consultant with a minimum of 20 years experience working with clinical research sites, CROs, pharmaceutical, medical device or biotechnology companies.
Our areas of clinical expertise
Allergy
Cardiovascular
Dermatology
Endocrinology
Gastroenterology
Haematology
Healthy Volunteers
Hepatic
Immunotherapeutics
Infectious Disease
Medical Devices
Neurology
Oncology
Ophthalmology
Orthopaedic
Pain
Paediatric
Psychiatry
Renal
Respiratory
Rheumatology
Sexual Health
Surgical
Urology
Lets have a chat about your project.
Fill out the form and we will be in touch.